In vivo hepatic magnetic resonance spectroscopy: clinical or research tool? (Q41191203)

28 September 2017

1 reference

title

In vivo hepatic magnetic resonance spectroscopy: clinical or research tool? (English)

1 reference

28 September 2017

Jalan R

1

1 reference

PubMed ID

8895024

28 September 2017

Taylor-Robinson SD

series ordinal

2

1 reference

PubMed ID

8895024

28 September 2017

Hodgson HJ

series ordinal

3

1 reference

28 September 2017

1 September 1996

1 reference

28 September 2017

Journal of Hepatology

1 reference

28 September 2017

25

1 reference

28 September 2017

3

1 reference

28 September 2017

414-424

1 reference

Review article: quantitative tests of liver function.

28 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Methodological problems in the use of indocyanine green to estimate hepatic blood flow and ICG clearance in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Lidocaine metabolite formation as a measure of liver function in patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Antipyrine clearance per unit volume liver: an assessment of hepatic function in chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Prognostic value of the aminopyrine breath test in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Caffeine: a model compound for measuring liver function.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Human in vivo NMR spectroscopy in diagnostic medicine: clinical tool or research probe?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

MR spectroscopy: clinical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

1 reference

7 January 2021

Resonance Absorption by Nuclear Magnetic Moments in a Solid

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Observation of tissue metabolites using 31P nuclear magnetic resonance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Examination of a case of suspected McArdle's syndrome by 31P nuclear magnetic resonance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

The trouble with spectroscopy papers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Spectroscopy and imaging with a 4 tesla whole-body MR system

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

In vivo magnetic resonance imaging and spectroscopy of humans with a 4 T whole-body magnet

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Safety considerations in MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Some considerations concerning susceptibility, longitudinal relaxation time constants and motion artifacts in vivo human spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Phospholipid metabolites as indicators of cancer cell function

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

13C and 31P NMR study of gluconeogenesis: utilization of 13C-labeled substrates by perfused liver from streptozotocin-diabetic and untreated rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Effect of L-alanine infusion on 31P nuclear magnetic resonance spectra of normal human liver: towards biochemical pathology in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Saturation effects in phosphorus-31 magnetic resonance spectra of the human liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Phospholipid bilayer contribution to 31P NMR spectra in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Broadband proton decoupling in human 31P NMR spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Phosphorylation status of liver by 31P-n.m.r. spectroscopy, and its implications for metabolic control. A comparison of 31P-n.m.r. spectroscopy (in vivo and in vitro) with chemical and enzymic determinations of ATP, ADP and Pi.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Effect of intravenous fructose on the P-31 MR spectrum of the liver: dose response in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

In vivo monitoring of fructose metabolism in the human liver by means of 31P magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Phosphorus-31 magnetic resonance spectroscopy of the human liver using chemical shift imaging techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Study of human liver disease with P-31 magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Prognosis in primary biliary cirrhosis: model for decision making

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

A study of patients with alcoholic liver disease by 31P nuclear magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

An in vivo 31P MRS study of patients with liver cirrhosis: progress towards a non-invasive assessment of disease severity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Multivariate analysis of prognostic factors in fulminant hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

31P magnetic resonance spectroscopy detects a functional abnormality in liver metabolism after acetaminophen poisoning

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Hepatic cancers and their response to chemoembolization therapy. Quantitative image-guided 31P magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Malignant hepatic tumors: P-31 MR spectroscopy with one-dimensional chemical shift imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Image localized 31P magnetic resonance spectroscopy of the human liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Liver tumors: follow-up with P-31 MR spectroscopy after local chemotherapy and chemoembolization

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Abnormal phosphomonoester signals in 31P MR spectra from patients with hepatic lymphoma. A possible marker of liver infiltration and response to chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Study of liver metabolism in glucose-6-phosphatase deficiency (glycogen storage disease type 1A) by P-31 magnetic resonance spectroscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

A Study of Galactose Intolerance in Human and Rat Liver In Vivo by 31P Magnetic Resonance Spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Study of hereditary fructose intolerance by use of 31P magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Hepatic allograft rejection: new developments in terminology, diagnosis, prevention, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

High resolution proton magnetic resonance spectroscopy of human brain and liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Natural-abundance 13C NMR study of glycogen repletion in human liver and muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

13C-nuclear magnetic resonance spectroscopy studies of hepatic glucose metabolism in normal subjects and subjects with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Broadband proton decoupled natural abundance 13C NMR spectroscopy of humans at 1.5 T

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Glycogen detection by in vivo 13C NMR: a comparison of proton decoupling and polarization transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Dynamic 13C-1H nuclear polarization of lipid methylene resonances applied to broadband proton-decoupled in vivo 13C MR spectroscopy of human breast and calf tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Kinetic modeling of in vivo--nuclear magnetic resonance spectroscopy data: 5-fluorouracil in liver and liver tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

19F-[1H] nuclear Overhauser effect and proton decoupling of 5-fluorouracil and alpha-fluoro-beta-alanine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

Human tumor fluorouracil trapping: clinical correlations of in vivo 19F nuclear magnetic resonance spectroscopy pharmacokinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

The non-invasive monitoring of low dose, infusional 5-fluorouracil and its modulation by interferon-alpha using in vivo 19F magnetic resonance spectroscopy in patients with colorectal cancer: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980131-0

7 January 2021

10.1016/S0168-8278(96)80131-0

Identifiers

DOI

1 reference

28 September 2017

1 reference

PubMed ID

8895024